Press Coverage

FDA Finds Fault with Some Insulin Pen Use Directions

Article on FDA letter to manufacturers of insulin pen needles asking for review of product labels and training materials mentions ISMP recommendations and alert about insulin pen misuse and emphasizes the need to ensure clear instructions are provided.

For the full text of the article, visit MedTech Dive online.

More News

Healthcare Leaders Urged to Avoid Severity Bias, Establish Just Culture In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, the Institute for Safe Medication Practices (ISMP) is emphasizing that the focus should be